#United States #New York #Class Action #Pomerantz Law Firm #PROCEPT BioRobotics

Pomerantz Law Firm Issues Investor Alert for PROCEPT BioRobotics

Pomerantz LLP, a renowned law firm specializing in securities litigation, has taken significant steps by announcing a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT). This legal action arises in response to alleged securities fraud and other unlawful business practices related to the company's financial disclosures. Investors who have suffered losses are encouraged to participate in this class action, with critical deadlines approaching quickly.

Overview of the Lawsuit

The class action lawsuit targets certain officers and directors of PROCEPT BioRobotics, suggesting their involvement in misleading statements that have adversely affected investors. Specifically, the firm is seeking individuals who acquired PROCEPT securities during specified periods, primarily between 2025 and 2026. Those interested in joining the lawsuit must act before September 22, 2026, to be considered for the position of Lead Plaintiff in the case. The firm advises investors to contact Danielle Peyton for further assistance and to provide relevant personal information related to their investments.

Issues Highlighted by the Lawsuit

The lawsuit emerged following disappointing earnings reports from PROCEPT, starting with the announcement of second-quarter earnings in August 2025. The company disclosed that it sold only 12,750 handpieces within the United States during this quarter, significantly below the expectations of the market. CFO Kevin Waters indicated that projections for the subsequent quarter were not optimistic, predicting shipments of approximately 13,350 units—underwhelming compared to market estimates.

In November 2025, further disappointment surfaced when PROCEPT's third-quarter sales figures again missed guidance expectations. The company reported sales of 13,225 handpieces and lowered its annual sales forecast, magnifying investor doubts about its market performance and management strategies. CEO Larry L. Wood acknowledged critical management shortcomings, such as ineffective inventory management, which had contributed to excessive inventory levels by customers.

By February 2026, reports revealed a drastic decline in sales, with a drop to just 9,400 handpieces sold in the fourth quarter. This alarming downward trend culminated in substantial stock price falls, leading to considerable losses for investors. Legal representation through the Pomerantz class action initiative offers a pathway for those impacted to seek justice.

Historical Context and the Role of Pomerantz LLP

Founded by the prominent attorney Abraham L. Pomerantz, Pomerantz LLP has built a reputation over 85 years for advocating on behalf of investors and holding corporations accountable for securities fraud, fiduciary breaches, and other misconduct. The firm has successfully secured numerous multimillion-dollar settlements and damages recoveries for class members throughout its history.

The current lawsuit against PROCEPT underscores the importance of transparency and fairness in corporate practices. As the case unfolds, affected investors are urged to maintain contact with Pomerantz LLP and stay informed about their rights and potential next steps.

For those wishing to participate in this class action, accessing the complaint and details about joining is available via the law firm's website at www.pomerantzlaw.com. As legal processes progress, the outcomes may establish important precedents for how allegations of corporate misconduct are handled in future securities class actions.

Investors affected by the alleged misconduct should not hesitate to seek counsel to ensure their voices are heard during this critical period. The Pomerantz team is committed to supporting investors through these challenging circumstances and advocating on their behalf.